46 studies found for:    Open Studies | "Hypoglycemic Agents"
Show Display Options
Rank Status Study
21 Unknown  The Effects of Hypolipemic and Antidiabetic Treatment on Cytokines
Conditions: Diabetes;   Dyslipidemia;   Inflammation;   Cytokines
Intervention: Drug: Metformin 1000mg, simvastatin 10mg and fenofibrate 100mg
22 Recruiting Efficacy and Safety of Lixisenatide Versus Placebo on Top of Basal Insulin and/or Oral Antidiabetic Treatment in Older Type 2 Diabetic Patients
Condition: Type 2 Diabetes
Interventions: Drug: lixisenatide (AVE0010);   Drug: placebo
23 Recruiting Evaluation of Blood Pressure Reduction, Safety, and Tolerability of Canagliflozin in Patients With Hypertension and Type 2 Diabetes Mellitus on Stable Doses of Anti-hyperglycemic and Anti-hypertensive Agents
Conditions: Diabetes Mellitus, Type 2;   Hypertension
Interventions: Drug: Canagliflozin;   Drug: Placebo
24 Recruiting A Trial Comparing the Glycaemic Control of Levemir® Administered Once Daily According to Two Insulin Detemir Titration Algorithms After 20 Weeks in Subjects With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin Treatment With or Without Other Anti-diabetic Drugs (OADs)
Conditions: Diabetes;   Diabetes Mellitus, Type 2
Intervention: Drug: insulin detemir
25 Recruiting Comparison of Two Titration Programs of Adding Insulin Detemir to OADs in Poorly Controlled Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Behavioral: Active titration algorithm;   Behavioral: Usual titration algorithm
26 Unknown  Shiga Progression of Diabetes, Nephropathy and Retinopathy
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Pioglitazone add on to SU or biguanide;   Drug: SU or Biguanide
27 Unknown  Influence of DPP-4 on Inflammatory Parameters in Diabetics: Gender Aspects
Conditions: Type 2 Diabetes Mellitus;   Cardiovascular Risk;   Endothelial Dysfunction
Intervention:
28 Not yet recruiting Investigation of the Effect of E.-Coli-Nissle as Supporting Therapy to Standard Care of Diabetes Mellitus Type II
Condition: Diabetes Mellitus Type II
Intervention: Drug: e.-coli-nissle
29 Unknown  Gastric Modulator (TANTALUS® System) Versus Insulin Treatment in Obese Type 2 Diabetic Patients - a Randomized Control Trial
Condition: Type 2 Diabetes Mellitus
Interventions: Device: Tantalus;   Drug: Insulin
30 Recruiting Impact of Combined of Lantus(Insulin Glargine) and Lyxumia (Lixisenatide) on Insulin Secretion and Gastric Emptying
Condition: Diabetes Mellitus
Intervention: Drug: Luyxumia versus Lantus
31 Not yet recruiting The Hellenic Postprandial Lipemia Study (HPLS)
Conditions: Coronary Heart Disease;   Dyslipidemia
Intervention:
32 Unknown  Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Type 2 Diabetes
Condition: Type 2 Diabetes
Intervention: Biological: MSC
33 Recruiting A Study of the Safety and Efficacy of MK-3102 in ≥18 and <45 Year-Old Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control (MK-3102-028 AM1)
Condition: Diabetes Mellitus
Interventions: Drug: MK-3102;   Drug: Placebo to MK-3102;   Drug: Metformin
34 Recruiting Effects of Alogliptin on Pancreatic Beta Cell Function
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Alogliptin;   Drug: Metformin 750 mg
35 Recruiting The Effects of Metformin on Functional Capacity in Individuals With Peripheral Artery Disease-Related Intermittent Claudication
Conditions: Peripheral Arterial Disease;   Intermittent Claudication
Interventions: Drug: Metformin;   Drug: Placebo
36 Unknown  The Inhibitory Effect of Metformin on Gluconeogenesis in Relation to Polymorphisms in Organic Cation Transporter 1
Condition: Pharmacogenetics of Metformin
Intervention: Drug: Metformin
37 Recruiting Liraglutide as add-on to Insulin in Type 1 Diabetes
Conditions: Diabetes;   Diabetes Mellitus, Type 1
Interventions: Drug: Liraglutide;   Drug: Placebo
38 Unknown  Predicting Response to Incretin Based Agents in Type 2 Diabetes
Condition: Type 2 Diabetes,
Intervention: Other: No intervention, observational study
39 Not yet recruiting Insulin Degludec and Symptomatic Nocturnal Hypoglycaemia
Conditions: Type 1 Diabetes Mellitus;   Nocturnal Hypoglycemia;   Recurrent Severe Hypoglycaemia
Interventions: Drug: Insulin aspart/glargine;   Drug: Insulin aspart/degludec
40 Unknown  Effects of PDE-5 Inhibition on Postprandial Hyperglycemia in Type 2 Diabetes
Condition: Type 2 Diabetes
Intervention: Drug: Tadalafil

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-46) Show next page of results
Indicates status has not been verified in more than two years